Cipak A - Search Results

1

An overview on anticancer activities of the Viscum album extract Isorel.

Zarkovic N, Vukovic T, Loncaric I, Miletic M, Zarkovic K, Borovic S, Cipak A, Sabolovic S, Konitzer M, Mang S. Zarkovic N, et al. Among authors: cipak a. Cancer Biother Radiopharm. 2001 Feb;16(1):55-62. doi: 10.1089/108497801750096041. Cancer Biother Radiopharm. 2001. PMID: 11279798

2

The influence of isorel on the advanced colorectal cancer.

Cazacu M, Oniu T, Lungoci C, Mihailov A, Cipak A, Klinger R, Weiss T, Zarkovic N. Cazacu M, et al. Among authors: cipak a. Cancer Biother Radiopharm. 2003 Feb;18(1):27-34. doi: 10.1089/108497803321269304. Cancer Biother Radiopharm. 2003. PMID: 12667306 Clinical Trial.

3

Anticancer and antioxidative effects of micronized zeolite clinoptilolite.

Zarkovic N, Zarkovic K, Kralj M, Borovic S, Sabolovic S, Blazi MP, Cipak A, Pavelic K. Zarkovic N, et al. Among authors: cipak a. Anticancer Res. 2003 Mar-Apr;23(2B):1589-95. Anticancer Res. 2003. PMID: 12820427

4

Possible involvement of 4-hydroxynonenal in splenocyte regulated liver regeneration.

Cipak A, Borovic S, Scukanec-Spoljar M, Kirac I, Zarkovic N. Cipak A, et al. Biofactors. 2005;24(1-4):217-26. doi: 10.1002/biof.5520240126. Biofactors. 2005. PMID: 16403957

5

Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Jaganjac M, Poljak-Blazi M, Schaur RJ, Zarkovic K, Borovic S, Cipak A, Cindric M, Uchida K, Waeg G, Zarkovic N. Jaganjac M, et al. Among authors: cipak a. Clin Exp Immunol. 2012 Nov;170(2):178-85. doi: 10.1111/j.1365-2249.2012.04639.x. Clin Exp Immunol. 2012. PMID: 23039888 Free PMC article.

6

The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells.

Sunjic SB, Cipak A, Rabuzin F, Wildburger R, Zarkovic N. Sunjic SB, et al. Among authors: cipak a. Biofactors. 2005;24(1-4):141-8. doi: 10.1002/biof.5520240117. Biofactors. 2005. PMID: 16403974

7

Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells.

Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G, Zarkovic N. Borovic S, et al. Among authors: cipak a. Redox Rep. 2007;12(1):50-4. doi: 10.1179/135100007X162194. Redox Rep. 2007. PMID: 17263909

8

Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain.

Juric-Sekhar G, Zarkovic K, Waeg G, Cipak A, Zarkovic N. Juric-Sekhar G, et al. Among authors: cipak a. Tumori. 2009 Nov-Dec;95(6):762-8. doi: 10.1177/030089160909500620. Tumori. 2009. PMID: 20210242

9

Pathophysiological relevance of aldehydic protein modifications.

Zarkovic N, Cipak A, Jaganjac M, Borovic S, Zarkovic K. Zarkovic N, et al. Among authors: cipak a. J Proteomics. 2013 Oct 30;92:239-47. doi: 10.1016/j.jprot.2013.02.004. Epub 2013 Feb 22. J Proteomics. 2013. PMID: 23438936 Review.

10

Bioactive 1,4-dihydroisonicotinic acid derivatives prevent oxidative damage of liver cells.

Borovic S, Tirzitis G, Tirzite D, Cipak A, Khoschsorur GA, Waeg G, Tatzber F, Scukanec-Spoljar M, Zarkovic N. Borovic S, et al. Among authors: cipak a. Eur J Pharmacol. 2006 May 10;537(1-3):12-9. doi: 10.1016/j.ejphar.2006.03.004. Epub 2006 Mar 10. Eur J Pharmacol. 2006. PMID: 16600211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page